Interferon Inducibility of STAT 1 Activation and Its Prognostic Significance in Melanoma Patients Cited by

Fol. Biol. 2003, 49, 142-146

https://doi.org/10.14712/fb2003049040142

V. Boudný, I. Kocák, L. Lauerová, Jan Kovařík

Department of Cellular and Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic

Received June 4, 2003
Accepted June 12, 2003

CHEN SHUXIN, LI CHUNQUAN, WU BINGLI, ZHANG CHUNLONG, LIU CHENG, LIN XIAOXU, WU XIANGQIAO, SUN LINGLING, LIU CHUNPENG, CHEN BO, ZHONG ZHIGANG, XU LIYAN, LI ENMIN: Identification of differentially expressed genes and their subpathways in recurrent versus primary bone giant cell tumors. International Journal of Oncology 2014, 45, 1133. <https://doi.org/10.3892/ijo.2014.2501>
Wellbrock Claudia, Weisser Christin, Hassel Jessica C., Fischer Petra, Becker Jürgen, Vetter Claudia S., Behrmann Iris, Kortylewski Marcin, Heinrich Peter C., Schartl Manfred: STAT5 Contributes to Interferon Resistance of Melanoma Cells. Current Biology 2005, 15, 1629. <https://doi.org/10.1016/j.cub.2005.08.036>